A5047856785- Pituitary Gland Disorders and Treatments
- Electrolyte and hormonal disorders
- Growth Hormone and Insulin-like Growth Factors
- Psychology of Development and Education
- Cerebrospinal fluid and hydrocephalus
- Traumatic Brain Injury and Neurovascular Disturbances
- Pharmacological Effects and Toxicity Studies
- Neuroendocrine Tumor Research Advances
- Ion Transport and Channel Regulation
- Adrenal and Paraganglionic Tumors
Burdenko Neurosurgery Institute
2021-2023
Introduction The tumors of the diencephalon region (thalamic-hypothalamic-pituitary system) include a large group: pituitary adenomas, craniopharyngiomas, gliomas, and others. Tumors differ in histological structure, manifestations clinical symptoms; by hormonal data; approaches methods treatment. Psychic symptoms are revealed disease addition to cerebral, neuroendocrine symptoms, neurological disorders. Psychoorganic syndrome is represented emotional, motivational, personal, cognitive...
Presented case demonstrates a rare diencephalic pathology — adipsic diabetes insipidus (ADI) with severe hypernatremia in 58-year-old woman after ttranssphenoidal removal of stalk intraventricular craniopharyngioma. ADI was diagnosed because (150–155 mmol/L), polyuria (up to 4 liters per day) and absence thirst. Normalization water-electrolyte balance occurred on the background desmopressin therapy sufficient hydration postoperative period. After release from hospital, patient independently...
Reset osmostat syndrome (ROS) is characterized by a change of normal plasma osmolality threshold (decrease or increase), which leads to chronic dysnatremia (hypo- hypernatremia). We have described clinical case ROS and hyponatremia in patient with chordoid glioma the III ventricle. It known that had previously been diagnosed (131–134 mmol/l). She has not hypothyroidism hypocorticism. There filtration function kidneys was (CKD-EPI 91.7 ml/mi/1,73m 2 ). Urine sodium level were studied exclude...
Treatment of acromegaly is still an unresolved problem. Overall postoperative remission rate ranges from 34 to 85%. These values are better for microadenomas (75-90%) and worse macroadenomas (45-70%). Identification predictors after surgical treatment urgent objective improve the quality medical care these patients.To analyze freedom remission.A retrospective single-center study included 227 patients with who underwent resection pituitary adenoma between August 2018 2021.Remission...